Vanucizumab (Anti-Angiopoietin 2 & VEGF)
Product Specifications
CAS Number
1448221-05-3
Synonyms
Anti-ANG2 & VEGFA, RG7221
SKU
C00928-1mg
Target
VEGFR
Applications
Protein Tyrosine Kinase
Additionnal Information
Vanucizumab is a humanized bispecific IgG1 antibody targeting VEGF-A and Ang-2 to inhibit tumor angiogenesis. It is being developed for the treatment of advanced solid tumors demonstrating anti-tumor, anti-angiogenic, and anti-metastatic effects. M.W 146.89 kDa
Storage Conditions
-80°C (avoid freeze-thaw cycles)
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog